(Boursier.com) — Valneva Vaccine company SE announced today that it will present on its single-shot chikungunya vaccine candidate, VLA1553, at the eighth North European Travel Medicine Conference on June 9 in Rotterdam.
Vera Bürger, Director of Clinical Strategy at Valneva, will present a summary on the clinical development of VLA1553.
Valneva will also hold a symposium on Friday June 10, 2022 at 12:30 CEST bringing together Assistant Professor Johanna Lindahl, Veterinary Epidemiologist, and Professor of Medicine Tomas Jelinek.
Further information on the presentation, symposium and conference registration is available on the event website: https://mkon.nu/nectm_8.
Event Information:
8th Northern European Conference on Travel Medicine (“NECTM8”)
Venue: De Doelen International Conference Center Rotterdam
Schouwburgplein 50
Rotterdam, Netherlands
When: Thursday, June 9, 2022
Time: 9:00 CEST
©2022 Boursier.com